Targeting Stage 4 Cancer beyond Chemo
One tactic cancer cells and stage 4 cancers employ to develop and progress is by avoiding programmed cell death (apoptosis.) In a normal body, apoptosis is the naturally-occurring process by which the body maintains healthy tissue function by disposing of damaged cells. It is triggered by signals, including cell stress and DNA damage. In many cancer patients, we see the process of apoptosis averted. This allows cancer cells to continue to endure. In a healthy person, we may see apoptosis protect us from potential cancer situations up to 10,000 times per day; so what we must ask ourselves is “why then do Stage 4 Cancer patients divert this natural process?” Mutations Bring About Stubborn and Resistant Stage 4 Cancers Both internal and external cellular triggers can commence apoptosis. To catalyze internally, the process relies on protein p53. In the event of certain mutations to this protein’s gene, the protein can become inactive, thereby inhibiting internally-triggered apoptosis functionality. This mutation is seen in up to 50 percent of all human cancers. By targeting this mutation, cancer treatments are enhanced significantly. Stage 4 Cancers May Dodge Chemotherapy It is common knowledge that radiation’s and chemotherapy’s ability to damage cell DNA, indirectly promotes apoptosis. However, cancer takes advantage of a tricky
loophole to side-step what should be imminent trouble for its cells. As mutations to protein p53 can shut down apoptosis from within the cell, in such circumstance, cancer cells can escape the harm of conventional stage 4 treatments meant to wipe it out. Because Envita has seen this repeatedly over the last decade plus of working with the most difficult cancers, we have become proactive. Our protocols call for preventative treatments designed to overcome p53 oncogene mutations through specialized nutrition, and encouraging healthy apoptosis. Recognizing that nutritional, immunological, or impairments in toxin elimination deficiencies can create cancer-friendly environments is the first step. Taking action against the causes of these environments is what sets Envita apart. Launching an Offensive on Cancer By simultaneously catalyzing apoptosis outside and within the cell, it is possible to destroy cancer cells that were previously deemed conventional treatment-resistant. Depending upon the stage and cancer type, Envita has a variety of treatments to support mitochondria dysfunction – coupled with nutrients employed to restore healthy functionality. These unique treatments are a part of why Envita has such and impressive track record against advanced and stage 4 cancers. Treatment Improved – Results Achieved Envita’s Comprehensive Smart Oncology®(link to Envita cancer section) program integrates successful oncology combinations with our aggressive natural therapies that affect apoptosis in cancer cells by using tumor destruction methods that actually rely solely on p53. Visit our PPMR process( link to Envita home or ppmr) or contact us speak to one of our patient-care educators so that we can put an immediate plan in place for you.
http://www.envita.com/conditions-we-treat/cancer/stage-4cancer/ - Stage 4 Cancer is also known as Stage IV Cancer, which spread to various s...